Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-08
2011-10-04
Jarrell, Noble (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S011000
Reexamination Certificate
active
08030345
ABSTRACT:
The present invention relates to novel compounds of general formula (I),their regioisomers, tautomeric forms, novel intermediates involved in their synthesis. The present invention also relates to a process of preparing compounds of general formula (I), their regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.
REFERENCES:
patent: 01/32629 (2001-05-01), None
patent: 01/32663 (2001-05-01), None
Wermuth. The Practice of Medicinal Chemistry, 1996, pp. 203-237.
Grant et al. Clinical Neuroscience Research, 2005, 5, 185-199.
U.S. Appl. No. 12/769,861, filed Apr. 2010, Lohray.
Stoit, A. R.,et al. “Design, Synthesis and Biological Activity of Rigid Cannabinoid CB1Receptor Antagonists.”Chem Pharm. Bull(2002) vol. 50, No. 8, pp. 1109-1113.
Ruiu, S., et al. Synthesis and Characterization of NESS 0327: A Novel Putative Antagonist of the CB1Cannabinoid Receptor.:The Journal of Pharmacology and Experimental Therapeutics(2003) vol. 306, No. 1, pp. 363-370.
Fravolina, A., et al. “Synthesis and pharmacological activity of benzothiopyranopyrazole and benzothiopyranoisoxazole and benzothi opyranoisoxazole carboxamides.”FARMACO, Edizione Scientifica, Societa Chimica Italinana, Pavia, It.(1978) vol. 33, No. 11, pp. 855-865.
Mussinu, J-M., et al. “Tricyclic Pyrazoles. Part 1: Synthesis and Biological Evaluation of Novel 1,4-Dihydroindeno[1,2-c]pyrazol-based Ligands for CB1and CB2Cannabinoid Receptors.”Bioorganic&Medicinal Chemistry(2003) vol. 11, pp. 251-263.
Lohray Braj Bhushan
Lohray Vidya Bhushan
Srivastava Brijesh
Cadila Healthcare Limited
Jarrell Noble
Ladas & Parry LLP
LandOfFree
Tricyclic pyrazole derivatives as cannabinoid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic pyrazole derivatives as cannabinoid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic pyrazole derivatives as cannabinoid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4285694